Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease.

Dalbøge, Louise S; Christensen, Michael; Madsen, Martin Rønn; Secher, Thomas; Endlich, Nicole; Drenic', Vedran; Manresa-Arraut, Alba; Hansen, Henrik H; Rune, Ida; Fink, Lisbeth N; Østergaard, Mette V

Dalbøge, Louise S; Christensen, Michael; Madsen, Martin Rønn; Secher, Thomas; Endlich, Nicole; Drenic', Vedran; Manresa-Arraut, Alba; Hansen, Henrik H; Rune, Ida; Fink, Lisbeth N; Østergaard, Mette V.

Afiliação

Dalbøge LS; Gubra, DK-2970 Hoersholm, Denmark.
Christensen M; Gubra, DK-2970 Hoersholm, Denmark.
Madsen MR; Gubra, DK-2970 Hoersholm, Denmark.
Secher T; Gubra, DK-2970 Hoersholm, Denmark.
Endlich N; Center of High-End Imaging, NIPOKA GmbH, 17489 Greifswald, Germany.
Drenic' V; Center of High-End Imaging, NIPOKA GmbH, 17489 Greifswald, Germany.
Manresa-Arraut A; Gubra, DK-2970 Hoersholm, Denmark.
Hansen HH; Gubra, DK-2970 Hoersholm, Denmark.
Rune I; Gubra, DK-2970 Hoersholm, Denmark.
Fink LN; Gubra, DK-2970 Hoersholm, Denmark.
Østergaard MV; Vifor (International) Ltd., 9001 St. Gallen, Switzerland.

Biomedicines ; 10(7)2022 Jul 11.

Article em En | MEDLINE | ID: mdl-35884965

Palavras-chave

ACE inhibitor; GLP-1 receptor agonist; diabetic kidney disease; glomerulosclerosis; hypertension; mouse model; podocyte

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google